{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:44:39Z","timestamp":1788414279814,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","award":["SGZ-2018-11999"],"award-info":[{"award-number":["SGZ-2018-11999"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"crossref","award":["SGZ-2018-11999"],"award-info":[{"award-number":["SGZ-2018-11999"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["433722450"],"award-info":[{"award-number":["433722450"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["433722450"],"award-info":[{"award-number":["433722450"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e4tsmedizin Rostock"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interleukin (IL-) 6 is a critical factor in inflammatory processes of rheumatoid arthritis (RA). This is of high interest as the progression of RA may lead to the implantation of joint endoprostheses, which is associated with a pro-inflammatory increase in IL-6 in the periprosthetic tissue. Biological agents such as sarilumab have been developed to inhibit IL-6-mediated signaling. However, IL-6 signaling blockade should consider the inhibition of inflammatory processes and the regenerative functions of IL-6. This in vitro study investigated whether inhibiting IL-6 receptors can affect the differentiation of osteoblasts isolated from patients with RA. Since wear particles can be generated at the articular surfaces of endoprostheses leading to osteolysis and implant loosening, the potential of sarilumab to inhibit wear particle-induced pro-inflammatory processes should be investigated. Both in monocultures and indirect co-cultures with osteoclast-like cells (OLCs), human osteoblasts were stimulated with 50\u00a0ng\/mL each of IL-6\u2009+\u2009sIL-6R and in combination with sarilumab (250\u00a0nM) to characterize cell viability and osteogenic differentiation capacity. Furthermore, the influence of IL-6\u2009+\u2009sIL-6R or sarilumab on viability, differentiation, and inflammation was evaluated in osteoblasts exposed to particles. Stimulation with IL-6\u2009+\u2009sIL-6R and sarilumab did not affect cell viability. Except for the significant induction of <jats:italic>RUNX2<\/jats:italic> mRNA by IL-6\u2009+\u2009sIL-6R and a significant reduction with sarilumab, no effects on cell differentiation and mineralization could be detected. Furthermore, the different stimulations did not affect the osteogenic and osteoclastic differentiation of co-cultured cells. Compared to the osteoblastic monocultures, a decreased release of IL-8 was triggered in the co-culture. Among these, treatment with sarilumab alone resulted in the greatest reduction of IL-8. The co-culture also showed clearly increased OPN concentrations than the respective monocultures, with OPN secretion apparently triggered by the OLCs. Particle exposure demonstrated decreased osteogenic differentiation using different treatment strategies. However, sarilumab administration caused a trend toward a decrease in IL-8 production after stimulation with IL-6\u2009+\u2009sIL-6R. The blockade of IL-6 and its pathway have no significant effect on the osteogenic and osteoclastic differentiation of bone cells derived from patients with RA. Nonetheless, observed effects on the reduced IL-8 secretion need further investigation.<\/jats:p>","DOI":"10.1007\/s10238-023-01103-3","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T04:12:49Z","timestamp":1686111169000},"page":"3479-3499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["IL-6-induced response of human osteoblasts from patients with rheumatoid arthritis after inhibition of the signaling pathway"],"prefix":"10.1007","volume":"23","author":[{"given":"Marie-Luise","family":"Sellin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Klinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Bergschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Jonitz-Heincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"1103_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155238","author":"F Pandolfi","year":"2020","unstructured":"Pandolfi F, Franza L, Carusi V, et al. Interleukin-6 in rheumatoid arthritis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21155238.","journal-title":"Int J Mol Sci"},{"key":"1103_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040880","author":"Y-J Lin","year":"2020","unstructured":"Lin Y-J, Anzaghe M, Sch\u00fclke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9040880.","journal-title":"Cells"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","volume":"39","author":"M Noack","year":"2017","unstructured":"Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol. 2017;39:365\u201383. https:\/\/doi.org\/10.1007\/s00281-017-0619-z.","journal-title":"Semin Immunopathol"},{"key":"1103_CR4","doi-asserted-by":"publisher","first-page":"16879","DOI":"10.1074\/jbc.M200546200","volume":"277","author":"C Vermes","year":"2002","unstructured":"Vermes C, Jacobs JJ, Zhang J, et al. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem. 2002;277:16879\u201387. https:\/\/doi.org\/10.1074\/jbc.M200546200.","journal-title":"J Biol Chem"},{"key":"1103_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222010922","author":"N Kondo","year":"2021","unstructured":"Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222010922.","journal-title":"Int J Mol Sci"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/PROM.S147286","volume":"9","author":"C Crotti","year":"2018","unstructured":"Crotti C, Biggioggero M, Becciolini A, et al. Sarilumab: patient-reported outcomes in rheumatoid arthritis. Patient Relat Outcome Meas. 2018;9:275\u201384. https:\/\/doi.org\/10.2147\/PROM.S147286.","journal-title":"Patient Relat Outcome Meas"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40744-020-00219-2","volume":"7","author":"EG Favalli","year":"2020","unstructured":"Favalli EG. Understanding the role of interleukin-6 (IL-6) in the joint and beyond: a comprehensive review of il-6 inhibition for the management of rheumatoid arthritis. Rheumatol Ther. 2020;7:473\u2013516. https:\/\/doi.org\/10.1007\/s40744-020-00219-2.","journal-title":"Rheumatol Ther"},{"key":"1103_CR8","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.1074\/jbc.RA119.008074","volume":"294","author":"NE McGregor","year":"2019","unstructured":"McGregor NE, Murat M, Elango J, et al. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis. J Biol Chem. 2019;294:7850\u201363. https:\/\/doi.org\/10.1074\/jbc.RA119.008074.","journal-title":"J Biol Chem"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.3892\/etm.2020.8982","volume":"20","author":"DA Ciobanu","year":"2020","unstructured":"Ciobanu DA, Poenariu IS, Cr\u00eengu\u0219 L-I, et al. JAK\/STAT pathway in pathology of rheumatoid arthritis (Review). Exp Ther Med. 2020;20:3498\u2013503. https:\/\/doi.org\/10.3892\/etm.2020.8982.","journal-title":"Exp Ther Med"},{"key":"1103_CR10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/DDDT.S100302","volume":"11","author":"MG Raimondo","year":"2017","unstructured":"Raimondo MG, Biggioggero M, Crotti C, et al. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis. Drug Des Devel Ther. 2017;11:1593\u2013603. https:\/\/doi.org\/10.2147\/DDDT.S100302.","journal-title":"Drug Des Devel Ther"},{"key":"1103_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071390","author":"A Klinder","year":"2022","unstructured":"Klinder A, Waletzko-Hellwig J, Sellin M-L, et al. Effects of the interleukin-6 receptor blocker sarilumab on metabolic activity and differentiation capacity of primary human osteoblasts. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071390.","journal-title":"Pharmaceutics"},{"key":"1103_CR12","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.12659\/msm.900032","volume":"22","author":"J Szypu\u0142a","year":"2016","unstructured":"Szypu\u0142a J, Cabak A, Kilja\u0144ski M, et al. Comparison of biocompatibility of cemented vs. cementless hip joint endoprostheses based on postoperative evaluation of proinflammatory cytokine levels. Med Sci Monit. 2016;22:4830\u20135. https:\/\/doi.org\/10.12659\/msm.900032.","journal-title":"Med Sci Monit"},{"key":"1103_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.5435\/JAAOS-D-19-00016","volume":"27","author":"MB Zaid","year":"2019","unstructured":"Zaid MB, O\u2019Donnell RJ, Potter BK, et al. Orthopaedic osseointegration: state of the art. J Am Acad Orthop Surg. 2019;27:977\u201385. https:\/\/doi.org\/10.5435\/JAAOS-D-19-00016.","journal-title":"J Am Acad Orthop Surg"},{"key":"1103_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.micron.2005.07.008","volume":"36","author":"F Marco","year":"2005","unstructured":"Marco F, Milena F, Gianluca G, et al. Peri-implant osteogenesis in health and osteoporosis. Micron. 2005;36:630\u201344. https:\/\/doi.org\/10.1016\/j.micron.2005.07.008.","journal-title":"Micron"},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/jbm.a.36829","volume":"108","author":"Y Liu","year":"2020","unstructured":"Liu Y, Rath B, Tingart M, et al. Role of implants surface modification in osseointegration: a systematic review. J Biomed Mater Res A. 2020;108:470\u201384. https:\/\/doi.org\/10.1002\/jbm.a.36829.","journal-title":"J Biomed Mater Res A"},{"key":"1103_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5312\/wjo.v6.i2.172","volume":"6","author":"D Bitar","year":"2015","unstructured":"Bitar D, Parvizi J. Biological response to prosthetic debris. World J Orthop. 2015;6:172\u201389. https:\/\/doi.org\/10.5312\/wjo.v6.i2.172.","journal-title":"World J Orthop"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3892\/ijmm.2011.778","volume":"28","author":"K Lochner","year":"2011","unstructured":"Lochner K, Fritsche A, Jonitz A, et al. The potential role of human osteoblasts for periprosthetic osteolysis following exposure to wear particles. Int J Mol Med. 2011;28:1055\u201363. https:\/\/doi.org\/10.3892\/ijmm.2011.778.","journal-title":"Int J Mol Med"},{"key":"1103_CR18","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/jcp.26076","volume":"233","author":"S Schulze","year":"2018","unstructured":"Schulze S, Wehrum D, Dieter P, et al. A supplement-free osteoclast-osteoblast co-culture for pre-clinical application. J Cell Physiol. 2018;233:4391\u2013400. https:\/\/doi.org\/10.1002\/jcp.26076.","journal-title":"J Cell Physiol"},{"key":"1103_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fimmu.2018.00831","volume":"9","author":"A Klinder","year":"2018","unstructured":"Klinder A, Seyfarth A, Hansmann D, et al. Inflammatory response of human peripheral blood mononuclear cells and osteoblasts incubated with metallic and ceramic submicron particles. Front Immunol. 2018;9:831. https:\/\/doi.org\/10.3389\/fimmu.2018.00831.","journal-title":"Front Immunol"},{"key":"1103_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113486","author":"A Jonitz-Heincke","year":"2018","unstructured":"Jonitz-Heincke A, Tillmann J, Ostermann M, et al. Label-free monitoring of uptake and toxicity of endoprosthetic wear particles in human cell cultures. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19113486.","journal-title":"Int J Mol Sci"},{"key":"1103_CR21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2016-210310","volume":"76","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Lin Y, Patel R, et al. Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial. Ann Rheum Dis. 2017;76:840\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210310.","journal-title":"Ann Rheum Dis"},{"key":"1103_CR22","unstructured":"Committee for Medicinal Products for Human Use. Kevzara\u2014Summary of Product Characteristics. Im Internet: https:\/\/www.medicines.org.uk\/emc\/product\/8143\/smpc; Stand: 02.01.2023"},{"key":"1103_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.782","volume":"102","author":"S Rose-John","year":"2017","unstructured":"Rose-John S. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation. Clin Pharmacol Ther. 2017;102:591\u20138. https:\/\/doi.org\/10.1002\/cpt.782.","journal-title":"Clin Pharmacol Ther"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s40259-018-0320-3","volume":"32","author":"AB Avci","year":"2018","unstructured":"Avci AB, Feist E, Burmester GR. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What\u2019s the Difference? BioDrugs. 2018;32:531\u201346. https:\/\/doi.org\/10.1007\/s40259-018-0320-3.","journal-title":"BioDrugs"},{"key":"1103_CR25","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1074\/jbc.RA117.001163","volume":"293","author":"P Baran","year":"2018","unstructured":"Baran P, Hansen S, Waetzig GH, et al. The balance of interleukin (IL)-6, IL-6\u00b7soluble IL-6 receptor (sIL-6R), and IL-6\u00b7sIL-6R\u00b7sgp130 complexes allows simultaneous classic and trans-signaling. J Biol Chem. 2018;293:6762\u201375. https:\/\/doi.org\/10.1074\/jbc.RA117.001163.","journal-title":"J Biol Chem"},{"key":"1103_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13287-017-0766-0","volume":"9","author":"Z Xie","year":"2018","unstructured":"Xie Z, Tang S, Ye G, et al. Interleukin-6\/interleukin-6 receptor complex promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2018;9:13. https:\/\/doi.org\/10.1186\/s13287-017-0766-0.","journal-title":"Stem Cell Res Ther"},{"key":"1103_CR27","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s00198-014-2779-1","volume":"25","author":"JL Pathak","year":"2014","unstructured":"Pathak JL, Bravenboer N, Verschueren P, et al. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts. Osteoporos Int. 2014;25:2453\u201363. https:\/\/doi.org\/10.1007\/s00198-014-2779-1.","journal-title":"Osteoporos Int"},{"key":"1103_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s00774-013-0514-1","volume":"32","author":"S Kaneshiro","year":"2014","unstructured":"Kaneshiro S, Ebina K, Shi K, et al. IL-6 negatively regulates osteoblast differentiation through the SHP2\/MEK2 and SHP2\/Akt2 pathways in vitro. J Bone Miner Metab. 2014;32:378\u201392. https:\/\/doi.org\/10.1007\/s00774-013-0514-1.","journal-title":"J Bone Miner Metab"},{"key":"1103_CR29","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara DS, Yun H, Kim S, et al. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018;18:e8. https:\/\/doi.org\/10.4110\/in.2018.18.e8.","journal-title":"Immune Netw"},{"key":"1103_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3325\/cmj.2016.57.89","volume":"57","author":"K Malysheva","year":"2016","unstructured":"Malysheva K, de Rooij K, Lowik CW, et al. Interleukin 6\/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts. Croat Med J. 2016;57:89\u201398. https:\/\/doi.org\/10.3325\/cmj.2016.57.89.","journal-title":"Croat Med J"},{"key":"1103_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-020-02163-6","volume":"22","author":"C Gabay","year":"2020","unstructured":"Gabay C, Burmester GR, Strand V, et al. Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. Arthritis Res Ther. 2020;22:70. https:\/\/doi.org\/10.1186\/s13075-020-02163-6.","journal-title":"Arthritis Res Ther"},{"key":"1103_CR32","doi-asserted-by":"publisher","first-page":"155742","DOI":"10.1016\/j.cyto.2021.155742","volume":"149","author":"M Jarlborg","year":"2022","unstructured":"Jarlborg M, Gabay C. Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. Cytokine. 2022;149:155742. https:\/\/doi.org\/10.1016\/j.cyto.2021.155742.","journal-title":"Cytokine"},{"key":"1103_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cyto.2008.05.007","volume":"43","author":"Y Li","year":"2008","unstructured":"Li Y, B\u00e4ckesj\u00f6 C-M, Haldos\u00e9n L-A, et al. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Cytokine. 2008;43:165\u201373. https:\/\/doi.org\/10.1016\/j.cyto.2008.05.007.","journal-title":"Cytokine"},{"key":"1103_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1359\/JBMR.0301256","volume":"19","author":"H Mitsuyama","year":"2004","unstructured":"Mitsuyama H, Kambe F, Murakami R, et al. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells. J Bone Miner Res. 2004;19:671\u20139. https:\/\/doi.org\/10.1359\/JBMR.0301256.","journal-title":"J Bone Miner Res"},{"key":"1103_CR35","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11033-021-06288-y","volume":"48","author":"S Berardi","year":"2021","unstructured":"Berardi S, Corrado A, Maruotti N, et al. Osteoblast role in the pathogenesis of rheumatoid arthritis. Mol Biol Rep. 2021;48:2843\u201352. https:\/\/doi.org\/10.1007\/s11033-021-06288-y.","journal-title":"Mol Biol Rep"},{"key":"1103_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010048","author":"M Aur\u00e9al","year":"2020","unstructured":"Aur\u00e9al M, Machuca-Gayet I, Coury F. Rheumatoid arthritis in the view of osteoimmunology. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom11010048.","journal-title":"Biomolecules"},{"key":"1103_CR37","doi-asserted-by":"publisher","first-page":"100934","DOI":"10.1016\/j.bbrep.2021.100934","volume":"26","author":"R Zou","year":"2021","unstructured":"Zou R, Huang X, Xu P. The study of gp130\/the inflammatory factors regulating osteoclast differentiation in rheumatoid arthritis. Biochem Biophys Rep. 2021;26:100934. https:\/\/doi.org\/10.1016\/j.bbrep.2021.100934.","journal-title":"Biochem Biophys Rep"},{"key":"1103_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00296-007-0506-3","volume":"28","author":"M Skoumal","year":"2008","unstructured":"Skoumal M, Haberhauer G, Kolarz G, et al. The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis. Rheumatol Int. 2008;28:637\u201341. https:\/\/doi.org\/10.1007\/s00296-007-0506-3.","journal-title":"Rheumatol Int"},{"key":"1103_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","volume":"15","author":"S Kwan Tat","year":"2004","unstructured":"Kwan Tat S, Padrines M, Th\u00e9oleyre S, et al. IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15:49\u201360. https:\/\/doi.org\/10.1016\/j.cytogfr.2003.10.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1103_CR40","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","volume":"182","author":"N Udagawa","year":"1995","unstructured":"Udagawa N, Takahashi N, Katagiri T, et al. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med. 1995;182:1461\u20138. https:\/\/doi.org\/10.1084\/jem.182.5.1461.","journal-title":"J Exp Med"},{"key":"1103_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8:656\u201364. https:\/\/doi.org\/10.1038\/nrrheum.2012.153.","journal-title":"Nat Rev Rheumatol"},{"key":"1103_CR42","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/art.24781","volume":"60","author":"R Axmann","year":"2009","unstructured":"Axmann R, B\u00f6hm C, Kr\u00f6nke G, et al. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 2009;60:2747\u201356. https:\/\/doi.org\/10.1002\/art.24781.","journal-title":"Arthritis Rheum"},{"key":"1103_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.1711760311","volume":"176","author":"AM Flanagan","year":"1995","unstructured":"Flanagan AM, Stow MD, Williams R. The effect of interleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro. J Pathol. 1995;176:289\u201397. https:\/\/doi.org\/10.1002\/path.1711760311.","journal-title":"J Pathol"},{"key":"1103_CR44","doi-asserted-by":"publisher","first-page":"11535","DOI":"10.1074\/jbc.M607999200","volume":"283","author":"F Yoshitake","year":"2008","unstructured":"Yoshitake F, Itoh S, Narita H, et al. Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J Biol Chem. 2008;283:11535\u201340. https:\/\/doi.org\/10.1074\/jbc.M607999200.","journal-title":"J Biol Chem"},{"key":"1103_CR45","doi-asserted-by":"publisher","first-page":"e919159","DOI":"10.12659\/MSM.919159","volume":"26","author":"J Si","year":"2020","unstructured":"Si J, Wang C, Zhang D, et al. Osteopontin in bone metabolism and bone diseases. Med Sci Monit. 2020;26:e919159. https:\/\/doi.org\/10.12659\/MSM.919159.","journal-title":"Med Sci Monit"},{"key":"1103_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018;59:17\u201324. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.07.003.","journal-title":"Clin Biochem"},{"key":"1103_CR47","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1136\/ard.2007.086710","volume":"67","author":"MC Kapetanovic","year":"2008","unstructured":"Kapetanovic MC, Lindqvist E, Saxne T, et al. Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement. Ann Rheum Dis. 2008;67:1412\u20136. https:\/\/doi.org\/10.1136\/ard.2007.086710.","journal-title":"Ann Rheum Dis"},{"key":"1103_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.semarthrit.2019.07.011","volume":"50","author":"C B\u00f6hler","year":"2020","unstructured":"B\u00f6hler C, Weimann P, Alasti F, et al. Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening. Semin Arthritis Rheum. 2020;50:245\u201351. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.07.011.","journal-title":"Semin Arthritis Rheum"},{"key":"1103_CR49","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1002\/art.37690","volume":"64","author":"B Ravi","year":"2012","unstructured":"Ravi B, Escott B, Shah PS, et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012;64:3839\u201349. https:\/\/doi.org\/10.1002\/art.37690.","journal-title":"Arthritis Rheum"},{"key":"1103_CR50","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1038\/srep05948","volume":"4","author":"K Chaudhari","year":"2014","unstructured":"Chaudhari K, Pradeep T. Spatiotemporal mapping of three dimensional rotational dynamics of single ultrasmall gold nanorods. Sci Rep. 2014;4:5948. https:\/\/doi.org\/10.1038\/srep05948.","journal-title":"Sci Rep"},{"key":"1103_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nano6030048","author":"C Yang","year":"2016","unstructured":"Yang C, Uertz J, Chithrani DB. Colloidal gold-mediated delivery of bleomycin for improved outcome in chemotherapy. Nanomaterials (Basel). 2016. https:\/\/doi.org\/10.3390\/nano6030048.","journal-title":"Nanomaterials (Basel)"},{"key":"1103_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1615\/jlongtermeffmedimplants.2014010562","volume":"24","author":"C Nich","year":"2014","unstructured":"Nich C, Goodman SB. Role of macrophages in the biological reaction to wear debris from joint replacements. J Long Term Eff Med Implants. 2014;24:259\u201365. https:\/\/doi.org\/10.1615\/jlongtermeffmedimplants.2014010562.","journal-title":"J Long Term Eff Med Implants"},{"key":"1103_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ma12172771","author":"A Jonitz-Heincke","year":"2019","unstructured":"Jonitz-Heincke A, Sellin M-L, Seyfarth A, et al. Analysis of cellular activity and induction of inflammation in response to short-term exposure to cobalt and chromium ions in mature human osteoblasts. Materials (Basel). 2019. https:\/\/doi.org\/10.3390\/ma12172771.","journal-title":"Materials (Basel)"},{"key":"1103_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/rheumatology\/ker257","volume":"51","author":"FG Goh","year":"2012","unstructured":"Goh FG, Midwood KS. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford). 2012;51:7\u201323. https:\/\/doi.org\/10.1093\/rheumatology\/ker257.","journal-title":"Rheumatology (Oxford)"},{"key":"1103_CR55","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3899\/jrheum.100732","volume":"38","author":"Y Tamaki","year":"2011","unstructured":"Tamaki Y, Takakubo Y, Hirayama T, et al. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol. 2011;38:810\u201320. https:\/\/doi.org\/10.3899\/jrheum.100732.","journal-title":"J Rheumatol"},{"key":"1103_CR56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fcell.2020.00352","volume":"8","author":"L Zhang","year":"2020","unstructured":"Zhang L, Haddouti E-M, Welle K, et al. The effects of biomaterial implant wear debris on osteoblasts. Front Cell Dev Biol. 2020;8:352. https:\/\/doi.org\/10.3389\/fcell.2020.00352.","journal-title":"Front Cell Dev Biol"},{"key":"1103_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00198-020-05664-x","volume":"32","author":"F Robin","year":"2021","unstructured":"Robin F, Cadiou S, Albert J-D, et al. Methotrexate osteopathy: five cases and systematic literature review. Osteoporos Int. 2021;32:225\u201332. https:\/\/doi.org\/10.1007\/s00198-020-05664-x.","journal-title":"Osteoporos Int"},{"key":"1103_CR58","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/8756-3282(94)00032-u","volume":"16","author":"DL Wheeler","year":"1995","unstructured":"Wheeler DL, Vander Griend RA, Wronski TJ, et al. The short- and long-term effects of methotrexate on the rat skeleton. Bone. 1995;16:215\u201321. https:\/\/doi.org\/10.1016\/8756-3282(94)00032-u.","journal-title":"Bone"},{"key":"1103_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/jbmr.3947","volume":"35","author":"JD Schepper","year":"2020","unstructured":"Schepper JD, Collins F, Rios-Arce ND, et al. Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis. J Bone Miner Res. 2020;35:801\u201320. https:\/\/doi.org\/10.1002\/jbmr.3947.","journal-title":"J Bone Miner Res"},{"key":"1103_CR60","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00228-004-0738-z","volume":"60","author":"EFL Dubois","year":"2004","unstructured":"Dubois EFL, Derks MGM, Schweitzer DH, et al. Pharmacokinetic\/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men. Eur J Clin Pharmacol. 2004;60:315\u201328. https:\/\/doi.org\/10.1007\/s00228-004-0738-z.","journal-title":"Eur J Clin Pharmacol"},{"key":"1103_CR61","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3892\/etm.2021.10172","volume":"22","author":"C Hadjicharalambous","year":"2021","unstructured":"Hadjicharalambous C, Alpantaki K, Chatzinikolaidou M. Effects of NSAIDs on pre-osteoblast viability and osteogenic differentiation. Exp Ther Med. 2021;22:740. https:\/\/doi.org\/10.3892\/etm.2021.10172.","journal-title":"Exp Ther Med"},{"key":"1103_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10165-006-0517-z","volume":"16","author":"E Torikai","year":"2006","unstructured":"Torikai E, Kageyama Y, Takahashi M, et al. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis. Mod Rheumatol. 2006;16:350\u20134. https:\/\/doi.org\/10.1007\/s10165-006-0517-z.","journal-title":"Mod Rheumatol"},{"key":"1103_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1359\/JBMR.041125","volume":"20","author":"FN Ton","year":"2005","unstructured":"Ton FN, Gunawardene SC, Lee H, et al. Effects of low-dose prednisone on bone metabolism. J Bone Miner Res. 2005;20:464\u201370. https:\/\/doi.org\/10.1359\/JBMR.041125.","journal-title":"J Bone Miner Res"},{"key":"1103_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0026-0495(98)90008-7","volume":"37","author":"E Ekenstam","year":"1988","unstructured":"Ekenstam E, St\u00e5lenheim G, H\u00e4llgren R. The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism. 1988;37:141\u20134. https:\/\/doi.org\/10.1016\/s0026-0495(98)90008-7.","journal-title":"Metabolism"},{"key":"1103_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","volume":"122","author":"Q Wang","year":"2017","unstructured":"Wang Q, Jiang H, Li Y, et al. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10\u201322. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.01.008.","journal-title":"Biomaterials"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01103-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:19:53Z","timestamp":1698783593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":65,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01103-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Rostock (Registration No. A 2018\u20130234 and approval date 10th December 2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}